CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of functional foods in the field of general health in China and internationally. It offers functional raw materials, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, doxofylline, and biological enzymes; and health food products, such as Guoweikangwei C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.
Stock data | 2024 | Change |
---|---|---|
Price | $3.44 | N/A |
Market Cap | $4.03B | N/A |
Shares Outstanding | 1.17B | N/A |
Employees | 0 | N/A |